|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191.26 USD | +1.49% |
|
-1.38% | -20.60% |
| 06-22 | KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating | MT |
| 06-17 | ResMed Shares Fall After Morgan Stanley Downgrade | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.49% | -1.38% | -8.07% | -16.10% | -20.60% | -24.85% | -11.15% | -21.42% | +198.47% | 27.62B | |
| +1.15% | -0.69% | +4.70% | -1.83% | -19.00% | +17.28% | -10.47% | -4.99% | +208.50% | 174B | |
| +0.06% | -3.33% | -7.97% | -15.66% | -28.81% | -21.73% | +23.20% | +33.59% | +448.69% | 143B | |
| +0.44% | -1.31% | +4.05% | -5.81% | -21.82% | -8.85% | -24.86% | -33.38% | +78.19% | 127B | |
| +2.86% | -2.81% | -21.08% | -34.43% | -52.18% | -55.45% | -15.51% | +4.13% | +98.52% | 67.78B | |
| +1.25% | -1.84% | +1.36% | +6.01% | +1.99% | +15.44% | -3.75% | -17.00% | +163.27% | 50.07B | |
| -0.83% | -0.92% | -2.25% | -6.48% | -23.58% | -26.80% | -32.07% | -32.55% | - | 43.84B | |
| +0.14% | -1.30% | +10.19% | +13.08% | -6.91% | +9.08% | +6.07% | -13.97% | +171.36% | 35.78B | |
| -0.29% | -0.93% | +4.33% | +18.35% | -5.96% | +4.19% | +37.47% | +2.95% | +158.09% | 35.07B | |
| +5.08% | +0.77% | -0.79% | -11.07% | -22.31% | -10.46% | -20.17% | - | - | 28.99B | |
| +0.17% | +1.30% | -1.47% | +1.25% | +0.90% | +14.45% | +28.45% | -39.86% | +16.96% | 25.37B | |
| -1.74% | -2.46% | -8.90% | -15.84% | -26.82% | -38.28% | -53.40% | -70.25% | - | 24.83B | |
| +2.20% | +0.40% | +14.21% | +33.23% | +25.75% | +82.02% | -18.22% | -64.84% | +12.51% | 24.95B | |
| +0.87% | -1.30% | +3.04% | +14.62% | +3.26% | +5.21% | -13.86% | -35.40% | +84.22% | 11.14B | |
| +0.40% | +2.02% | -9.57% | +16.80% | -17.13% | -13.08% | -26.81% | -27.97% | +76.59% | 10.77B | |
| -2.51% | -1.24% | +20.62% | +58.09% | +16.98% | +42.29% | -24.33% | -25.12% | +125.86% | 8.39B | |
| -0.85% | +6.70% | -16.25% | -22.88% | -25.90% | +23.63% | - | - | - | 3.88B | |
| +0.58% | +34.97% | +66.74% | +143.58% | +198.84% | +815.60% | +28.46% | -67.46% | -97.72% | 3.71B | |
| +0.20% | -4.65% | -19.60% | - | - | - | - | - | - | 3.43B | |
| -0.73% | +2.78% | -5.29% | +2.69% | -17.18% | -20.66% | -42.22% | - | - | 3.06B | |
| Average | +0.29% | +0.74% | +1.40% | +9.35% | -2.13% | +42.58% | -9.62% | -25.85% | +124.54% | 42.63B | |
| Weighted average by Cap. | +0.47% | -1.65% | -0.81% | -4.13% | -18.55% | -1.29% | -6.39% | -10.85% | +195.49% |
- Stock Market
- Stocks
- RMD Stock
- Sector ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
